PriceTargets.com logo

Neonc Technologies - NTHI Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $15.00
  • Forecasted Upside: 262.32%
  • Number of Analysts: 3
  • Breakdown:
  • 1 Sell Ratings
  • 1 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$4.14 As of 05/4/2026 05:00 PM ET
▲ +0.08 (1.97%)

This chart shows the closing price for NTHI by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Neonc Technologies Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for NTHI and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for NTHI

Analyst Price Target is $15.00
▲ +262.32% Upside Potential
This price target is based on 3 analysts offering 12 month price targets for Neonc Technologies in the last 3 months. The average price target is $15.00, with a high forecast of $15.00 and a low forecast of $15.00. The average price target represents a 262.32% upside from the last price of $4.14.

This chart shows the closing price for NTHI for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Hold

The current consensus among 3 polled investment analysts is to hold stock in Neonc Technologies. This rating changed within the last month from a Reduce consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/10/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
2/8/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
5/9/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
8/7/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 1 sell ratings
Ratings as of
11/5/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 1 sell ratings
Ratings as of
2/3/2026
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 1 sell ratings
Ratings as of
4/4/2026
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 1 sell ratings
Ratings as of
5/4/2026

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
4/24/2026BTIG ResearchInitiated CoverageBuy$15.00
4/24/2026BTIG ResearchInitiated CoverageBuy$15.00
3/27/2026Weiss RatingsReiterated RatingSell (E+) ➝ Sell (E+)
1/14/2026Zacks ResearchUpgradeHold
12/29/2025Weiss RatingsReiterated RatingSell (E+) ➝ Sell (E+)
12/22/2025Weiss RatingsReiterated RatingSell (E+) ➝ Sell (E+)
12/15/2025Weiss RatingsReiterated RatingSell (E+) ➝ Sell (E+)
12/8/2025Weiss RatingsReiterated RatingSell (E+) ➝ Sell (E+)
10/8/2025Weiss RatingsReiterated RatingSell (E) ➝ Sell (E)
9/27/2025Weiss RatingsReiterated RatingSell (E) ➝ Sell (E)
(Data available from 5/4/2021 forward)

News Sentiment Rating

0.95 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 7 positive mentions
  • 2 negative mentions
  • 1 very negative mentions
Mentions as of
10/6/2025
  • 1 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
Mentions as of
11/5/2025
  • 2 very positive mentions
  • 11 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/5/2025
  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/4/2026
  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/3/2026
  • 1 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/5/2026
  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/4/2026
  • 5 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/4/2026

Current Sentiment

  • 5 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

Neonc Technologies logo
Neonc Technologies Holdings, Inc. develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. Its lead products in development include NEO100, which is in Phase 2a clinical trials for treating glioblastoma; and NEO212, a covalently conjugated molecule combining the chemotherapeutic drug temozolomide with perillyl alcohol that is completed preclinical testing. The company was incorporated in 2023 and is based in Los Angeles, California.
Read More

Today's Range

Now: $4.14
Low: $4.00
High: $4.22

50 Day Range

MA: $7.20
Low: $4.30
High: $10.22

52 Week Range

Now: $4.14
Low: $3.20
High: $12.99

Volume

60,298 shs

Average Volume

56,093 shs

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Neonc Technologies?

The following Wall Street sell-side analysts have issued research reports on Neonc Technologies in the last year: BTIG Research, Weiss Ratings, and Zacks Research.
View the latest analyst ratings for NTHI.

What is the current price target for Neonc Technologies?

0 Wall Street analysts have set twelve-month price targets for Neonc Technologies in the last year. Their average twelve-month price target is $15.00, suggesting a possible upside of 262.3%. BTIG Research has the highest price target set, predicting NTHI will reach $15.00 in the next twelve months. BTIG Research has the lowest price target set, forecasting a price of $15.00 for Neonc Technologies in the next year.
View the latest price targets for NTHI.

What is the current consensus analyst rating for Neonc Technologies?

Neonc Technologies currently has 1 sell rating, 1 hold rating and 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in NTHI, but not buy more shares or sell existing shares.
View the latest ratings for NTHI.

What other companies compete with Neonc Technologies?

Other companies that are similar to Neonc Technologies include Ainos, Alvotech, Aravive, Atlantic Coastal Acquisition Corp. II and Avidity Biosciences. Learn More about companies similar to Neonc Technologies.

How do I contact Neonc Technologies' investor relations team?

Neonc Technologies' physical mailing address is 8335 Sunset Boulevard, Suite 240, Los Angeles, CA 90069, United States. The company's listed phone number is 310-663-7831. The official website for Neonc Technologies is www.neonctech.com. Learn More about contacing Neonc Technologies investor relations.